JW LIFESCIENCE CORPORATION (234080) Stock Statistics & Valuation Metrics

JW LIFESCIENCE CORPORATION has a market cap or net worth of ₩172.50B. The enterprise value is $227.87K.

JW LIFESCIENCE CORPORATION has 15,834,554 shares outstanding. The number of shares has decreased by -2.65% in one year.

JW LIFESCIENCE CORPORATION’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 10.60%.

The current PE Ratio of JW LIFESCIENCE CORPORATION is 5.9. JW LIFESCIENCE CORPORATION’s PEG ratio is -0.20.

In the last 12 months, JW LIFESCIENCE CORPORATION had revenue of 257.83B and earned 28.61B in profits. Earnings per share was 1.85K.

In the last 12 months, operating cash flow was 47.38B and capital expenditures -12.84B, giving a free cash flow of 34.54B billion.

JW LIFESCIENCE CORPORATION pays an annual dividend of ―, resulting in a dividend yield of ―

JW LIFESCIENCE CORPORATION upcoming earnings date is Aug 18, 2026, TBA (Confirmed).

JW LIFESCIENCE CORPORATION as a current ratio of 1.05, with Debt / Equity ratio of 19.31%

In the past 12 months, JW LIFESCIENCE CORPORATION has paid 3.14B in taxes.

JW LIFESCIENCE CORPORATION EV to EBITDA ratio is 4.68, with an EV/FCF ratio of 8.60.

JW LIFESCIENCE CORPORATION has ₩12.20B in cash and marketable securities with ₩42.25B in debt, giving a net cash position of -₩30.05B billion.

Gross margin is 29.22%, with operating margin of 12.92%, and net profit margin of 11.09%.

The average price target for JW LIFESCIENCE CORPORATION is ―, which is 11.43% higher than the current price. The consensus rating is ―